The Effect of Crocin and Losartan on Biochemical Parameters and Oxidative Stress Markers in Diabetic Nephropathy Rats Model

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 144

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JKMU-29-4_005

تاریخ نمایه سازی: 19 دی 1401

Abstract:

Background: Diabetic nephropathy (DN) is the most common cause of the end-stage renal disease (ESRD) globally. This study aimed to evaluate the effect of Crocin and Losartan on DN in diabetic rats.Methods: A single dose of Streptozotocin (۵۰ mg/kg IP) was administered to ۴۰ male Wistar rats to induce diabetes. Crocin and Losartan (۵۰ and ۲۵ mg/kg, respectively) were given orally for four weeks. The study groups were untreated control, Diabetes, Crocin, Losartan, and Losartan-Crocin. At the end of the intervention, blood was tested for FBS, urea, UA, Cr, albumin, TG, TC, LDL-C, HDL-C, TAC, and MDA.Results: Serum levels of FBS, urea, UA, TG, TC, and LDL-C increased significantly in the diabetic group compared to the untreated control group (P = ۰.۰۰۱), while albumin and HDL-C decreased significantly (P = ۰.۰۰۱). In the Crocin group, serum FBS, urea, TG, TC, and LDL-C levels were significantly lower than the diabetic group (P = ۰.۰۰۱), while serum albumin levels were significantly higher (P = ۰.۰۲). Serum levels of TAC and MDA in the Losartan group increased (P=۰.۰۴) and decreased significantly (P = ۰.۰۰۱) compared to the diabetic group, respectively.Conclusion: The findings of the present study showed that Crocin could control hyperglycemia and prevent DN progression. It appears that combining Losartan with sufficient doses of Crocin improves its efficacy. However, understanding the exact mechanism of these changes requires further studies.

Authors

Yaser Mohammadi

Qaen School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran & Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran

Fatemeh Salmani

Departments of Epidemiology and Biostatistics, School of Health Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran

Mohammad Zangooei

Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Azam Rezaei Farimani

Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran & Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, ...
  • Baek JH, Lee WJ, Lee BW, Kim SK, Kim G, ...
  • Papadopoulou-Marketou N, Paschou SA, Marketos N, Adamidi S, Adamidis S, ...
  • Zhang L, Wen Z, Han L, Zheng Y, Wei Y, ...
  • Rianto F, Hoang T, Revoori R, Sparks MA. Angiotensin receptors ...
  • Koszegi S, Molnar A, Lenart L, Hodrea J, Balogh DB, ...
  • Pechlivanova D, Krumova E, Kostadinova N, Mitreva-Staleva J, Grozdanov P, ...
  • Hussain MA, Abogresha NM, AbdelKader G, Hassan R, Abdelaziz EZ, ...
  • Elsherbiny NM, El-Sherbiny M, Said E. Amelioration of experimentally induced ...
  • Benzie IF, Strain JJ. The ferric reducing ability of plasma ...
  • Asri-Rezaei S, Tamaddonfard E, Ghasemsoltani-Momtaz B, Erfanparast A, Gholamalipour S. ...
  • Samarghandian S, Azimi-Nezhad M, Borji A, Farkhondeh T. Effect of ...
  • Kang C, Lee H, Jung ES, Seyedian R, Jo M, ...
  • Sefidgar SM, Ahmadi-Hamedani M, Jebelli Javan A, Narenji Sani R, ...
  • Talebanzadeh S, Ashrafi M, Kazemipour N, Erjaee H, Nazifi S. ...
  • Yaribeygi H, Noroozadeh A, Taghi-Mohammadi M, Johnston TP, Sahebkar AH. ...
  • Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, ...
  • Abou-Hany HO, Atef H, Said E, Elkashef HA, Salem HA. ...
  • Lee YJ, Cho S, Kim SR, Jang HR, Lee JE, ...
  • El-Fawal R, El Fayoumi HM, Mahmoud MF. Diosmin and crocin ...
  • Amin SN, El-Gamal EM, Rashed LA, Kamar SS, Haroun MA. ...
  • Altinoz E, Oner Z, Elbe H, Cigremis Y, Turkoz Y. ...
  • Yaribeygi H, Mohammadi MT, Rezaee R, Sahebkar AH. Crocin improves ...
  • Chang DC, Xu X, Ferrante-Jr AW, Krakoff J. Reduced plasma ...
  • Zhang J, Zhang R, Wang Y, Li H, Han Q, ...
  • Iwasaki T, Togashi Y, Terauchi Y. Significant association of serum ...
  • Nandini HS, Naik PR. Action of corilagin on hyperglycemia, hyperlipidemia ...
  • Naserizadeh SK, Taherifard MH, Shekari M, Mesrkanlou HA, Asbaghi O, ...
  • Fajriana H, Farmawati A, Arsanti-Lestari L. Antioxidant effect of purple ...
  • Nair AR, Ebenezer PJ, Saini Y, Francis J. Angiotensin II-induced ...
  • Ateyya H, Nader MA, El-Sherbeeny NA. Beneficial effects of rosiglitazone ...
  • نمایش کامل مراجع